Received: 14 May 2022
Accepted: 25 August 2022
First Online: 6 September 2022
: This study was submitted and approved by the local ethical review committee (Approval No.: 2020-0380). The authors obtained written informed consent from patients who were hospitalized between April and September 2021. Furthermore, all data used in this study, including HRQOL and FIM, had been measured as part of routine care for patients with brain tumors since April 2016 at the institution. Therefore, patients undergoing rehabilitation from April 2016 to March 2019 we offered the opportunity to opt-out to use data.
: Not applicable.
: The authors declare that they have no competing interests.